Journal
JOURNAL OF PROTEOME RESEARCH
Volume 10, Issue 4, Pages 1538-1547Publisher
AMER CHEMICAL SOC
DOI: 10.1021/pr1009096
Keywords
Alzheimer's; oligomeric; amyloid-beta; protein array; protein chip; proteomics; interactome
Categories
Funding
- Hungarian National Office for Research and Technology [NAP_BIO_06]
- Hungarian Academy of Sciences
- European Union [HEALTH-F2-2007-201159, HEALTH-F2-2007-211696]
- Hungarian Scientific Research Fund [OTKA NK 73672]
Ask authors/readers for more resources
Oligomeric amyloid-P is currently of interest in amyloid-P mediated toxicity and the pathogenesis of Alzheimer's disease. Mapping the amyloid-beta interaction partners could help to discover novel pathways in disease pathogenesis. To discover the amyloid-beta interaction partners, we applied a protein array with more than 8100 unique recombinantly expressed human proteins. We identified 324 proteins as potential interactors of oligomeric amyloid-P. The Gene Ontology functional analysis of these proteins showed that oligomeric amyloid-beta bound to multiple proteins with diverse functions both from extra and intracellular localizations. This undiscriminating binding phenotype indicates that multiple protein interactions mediate the toxicity of the oligomeric amyloid-beta. The most highly impacted cellular system was the protein translation machinery. Oligomeric amyloid-beta could bind to altogether 24 proteins involved in translation initiation and elongation. The binding of amyloid-beta to purified rat hippocampal ribosomes validated the protein array results. More importantly, in vitro translation assays showed that the oligomeric amyloid-beta had a concentration dependent inhibitory activity on translation. Our results indicate that the inhibited protein synthesis is one of the pathways that can be involved in the amyloid-beta induced neurotoxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available